PharmaShots | Incisive News in 3 Shots

Subscribe Now

Fibrotic Diseases

Bayer Collaborates with Recursion to Fortify Digital Drug Discovery for Fibrotic Diseases

Bayer Collaborates with Recursion to Fortify Digital Drug Discovery for Fibrotic Diseases

September 10, 2020

AbbVie Exercises its Option to License Morphosys' αvβ6 Integrin Inhibitor Program for Fibrotic Disease

AbbVie Exercises its Option to License Morphosys' αvβ6 Integrin Inhibitor Program for Fibrotic Disease

August 25, 2020

Innovent Signs a Clinical Trial Agreement with Sirnaomics to Treat Cancer and Fibrotic Diseases in the US

Innovent Signs a Clinical Trial Agreement with Sirnaomics to Treat Cancer and Fibrotic Diseases in the US

January 8, 2020

Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases

Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases

October 24, 2019

Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M

Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M

January 14, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us